Oncotelic Therapeutics, Inc. Convertible Notes Payable, Noncurrent
Oncotelic Therapeutics, Inc. (OTLC) had Convertible Notes Payable, Noncurrent of $37.03 thousand as of 2023-06-30, per its 10-Q filed 2023-08-18.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:ConvertibleLongTermNotesPayable · last filed 2023-11-14
- 2023-06-30: Convertible Notes Payable, Noncurrent $37.03K.
- 2023-03-31: Convertible Notes Payable, Noncurrent $349.36K.
- 2022-12-31: Convertible Notes Payable, Noncurrent $339.69K.
- 2022-09-30: Convertible Notes Payable, Noncurrent $178.48K.
| Period end | Convertible Notes Payable, Noncurrent |
|---|---|
| 2023-06-30 | $37.03K 10-Q · filed 2023-08-18 |
| 2023-03-31 | $349.36K 10-Q · filed 2023-05-22 |
| 2022-12-31 | $339.69K 10-Q · filed 2023-11-14 |
| 2022-09-30 | $178.48K 10-Q · filed 2022-11-18 |
| 2021-12-31 | $76.99K 10-K/A · filed 2023-04-20 |